The peripheral dose due to MV‐CBCT imaging, although small compared to the dose from the MV treatment beam, may be significant if the MV‐CBCT procedure is applied daily and, therefore, should be taken into account when planning IGRT using MV‐CBCT technology.
← all excerpts
Peripheral dose from megavoltage cone-beam CT imaging for nasopharyngeal carcinoma image-guided radiation therapy.
1
—
—